These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 17254529)
21. Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection. Rutkowski P; Dębiec-Rychter M; Nowecki Z; Michej W; Symonides M; Ptaszynski K; Ruka W J Eur Acad Dermatol Venereol; 2011 Mar; 25(3):264-70. PubMed ID: 20569296 [TBL] [Abstract][Full Text] [Related]
22. Imatinib in the treatment of dermatofibrosarcoma protuberans. Labropoulos SV; Razis ED Biologics; 2007 Dec; 1(4):347-53. PubMed ID: 19707305 [TBL] [Abstract][Full Text] [Related]
23. Current treatment options for dermatofibrosarcoma protuberans. Rutkowski P; Debiec-Rychter M Expert Rev Anticancer Ther; 2015; 15(8):901-9. PubMed ID: 26027711 [TBL] [Abstract][Full Text] [Related]
24. PDGFB rearrangement in dermatofibrosarcoma protuberans: correlation with clinicopathologic characteristics and clinical implications. Ha SY; Lee SE; Kwon MJ; Kim YJ; Lee EH; Seo J; Jang KT; Lee J; Choi YL Hum Pathol; 2013 Jul; 44(7):1300-9. PubMed ID: 23347652 [TBL] [Abstract][Full Text] [Related]
26. Imatinib mesylate for children with dermatofibrosarcoma protuberans (DFSP). Gooskens SL; Oranje AP; van Adrichem LN; de Waard-van der Spek FB; den Hollander JC; van de Ven CP; van den Heuvel-Eibrink MM Pediatr Blood Cancer; 2010 Aug; 55(2):369-73. PubMed ID: 20582941 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP). Stacchiotti S; Pantaleo MA; Negri T; Astolfi A; Tazzari M; Dagrada GP; Urbini M; Indio V; Maestro R; Gronchi A; Fiore M; Dei Tos AP; Conca E; Palassini E; Vincenzi B; Grosso F; Pilotti S; Castelli C; Casali PG Clin Cancer Res; 2016 Feb; 22(4):837-46. PubMed ID: 26261104 [TBL] [Abstract][Full Text] [Related]
28. Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment. Sirvent N; Maire G; Pedeutour F Genes Chromosomes Cancer; 2003 May; 37(1):1-19. PubMed ID: 12661001 [TBL] [Abstract][Full Text] [Related]
29. Imatinib Treatment for Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans: A Systematic Review. Navarrete-Dechent C; Mori S; Barker CA; Dickson MA; Nehal KS JAMA Dermatol; 2019 Mar; 155(3):361-369. PubMed ID: 30601909 [TBL] [Abstract][Full Text] [Related]
30. [Advanced dermatofibrosarcoma protuberans treated with imatinib mesylate]. Zhu JH; Li QW; Xiao WH; Sun JZ; Wang RL; Lu JY Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):470-2. PubMed ID: 21875491 [TBL] [Abstract][Full Text] [Related]
36. Imatinib mesylate in a patient with metastatic disease originating from a dermatofibrosarcoma protuberans of the scalp. Kasper B; Lossignol D; Gil T; Flamen P; De Saint Aubain N; Awada A Anticancer Drugs; 2006 Nov; 17(10):1223-5. PubMed ID: 17075323 [TBL] [Abstract][Full Text] [Related]
37. Genetic aberrations in imatinib-resistant dermatofibrosarcoma protuberans revealed by whole genome sequencing. Hong JY; Liu X; Mao M; Li M; Choi DI; Kang SW; Lee J; La Choi Y PLoS One; 2013; 8(7):e69752. PubMed ID: 23922791 [TBL] [Abstract][Full Text] [Related]